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Airways are exposed to high level of environmental 
oxidants and the inflammatory cells infiltrating the 
airways produce several inflammatory mediators 
including a range of toxic reactive oxygen species 
(ROS)1. The mechanism by which oxygen radicals 
cause asthma pathology is oxidation or nitration of 
proteins, lipids, or DNA to cause dysfunction of 
these molecules. In addition, physiological 
antioxidant system is impaired in asthma, possibly 
because of inflammation. Thus, the imbalance 
between oxidants and antioxidants that is called 
oxidant stress is critical to asthma pathogenesis2. 
Malondialdehyde (MDA), is a marker of lipid 
peroxidation3. Oxidative stress may have many 
effects on airway function, including airway smooth 
muscle contraction, induction of airway hyper- 
responsiveness, mucous hyper-secretion, epithelial 
shedding and vascular exudation. Furthermore, 
ROS and lipid peroxidation products can influence 
the inflammatory response at many levels through 
its impact on signal transduction mechanisms, 
activation of redox-sensitive transcription factors, 
and chromatin regulation resulting in pro-
inflammatory cytokine and chemokine gene 
expression and production4.    
Fortunately, the body has its own antioxidant 
mechanisms, including enzyme systems and non-
enzymatic molecules, which help in preventing 
severe damage from occurring5.Antioxidant 
enzymes, such as superoxide dismutases (SOD) and 
glutathione peroxidases (GPx) play an important 
role in offering protection to the airways against 
oxidative stress. Superoxide dismutases convert 
superoxide to hydrogen peroxide which is 
eliminated by glutathione peroxidase. SOD gets 
inactivated by reactive oxygen and nitrogen species. 
Thus antioxidant defense is impaired in hyperactive 
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airways. The situation gets further aggravated 
during acute exacerbations of asthma. 
So, the inflammation of the bronchial tree and 
enhanced systemic oxidative stress is related to an 
alteration of antioxidant enzyme activities in 
childhood asthma6. 
This study aimed at determination of the 
oxidant - antioxidant status in asthmatic children, 
by measuring the activities of antioxidant enzymes; 
superoxide dismutases (SOD) and glutathione 
peroxidases (Gpx) and the plasma level of 
malondialdehyde (MDA) as an index of lipid 
peroxidation. It also aimed to find a relation 
between antioxidant levels and the severity of 
asthma and the early response to treatment. 
 
METHODS 
This is a prospective case/control study carried out 
over the period (from 15 February 2009 to15 July 
2012) at Pediatric and Biochemistry Departments. 
The study included children; 1-11 years old who 
were attending Zagazig University Children 
Hospital or the outpatient clinic. They were divided 
into two groups; Group (1): 40 known asthmatic 
cases (24 males and 16 females) who presented to 
the hospital with acute attacks of asthma. Group 
(2): 20 healthy children as a control group (12 
males and 8 females). 
Asthma was diagnosed on clinical grounds 
according to GINA guidelines7 and based on history 
of recurrent or persistent wheezing with or without   
dyspnea, and improvement on use of β2-agonists8,9.  
Exclusion criteria included patients who had 
evidence of other concurrent pulmonary or systemic 
disease or of any upper or lower respiratory tract 
infection or who had an acute severe exacerbation 
of asthma or hospitalization within the last week. 
Patients who were taking vitamin containing tonics 
were excluded. Infants under one year of age were 
excluded because of uncertainty of the diagnosis in 
this age group. 
Patients were classified according to the 
disease severity into three groups: mild, moderate 
and severe persistent asthma. The severity of 
asthma was classified according to GINA 
guidelines 20047-9. 
For all patients, a full medical history taking 
and clinical examination were done to diagnose and 
classify asthma severity10. Blood sampling was 
obtained twice; first at the time of presentation 
during acute attack, and the second after 48 hours 
of treatment with β2-agonist {inhaled form for 
hospitalized cases (19 asthmatic children) and oral 
form for outpatient cases (11 asthmatic children)} 
and oral corticosteroids (prednisone 1-2 mg/kg 
maximum dose 60mg/ day divided into 3 doses).  
 
Methodology 
Two milliliters of peripheral venous blood were 
taken by venipuncture and collected in EDTA 
containing tubes. Blood samples were centrifuged 
for 10 minutes at 4000 rpm and then the plasma 
was aspirated off. The erythrocytes were washed 
four times with 3 ml of 0.9% NaCl solution, and 
centrifuged for 10 minutes at 4000 rpm after each 
wash. The washed centrifuged erythrocytes was 
then made up to 2.0 ml with cold distilled water, 
mixed and left to stand at +4˚C for 15 minutes. 
Samples were stored at -70˚C till time of use. 
Plasma MDA and erythrocytes SOD and Gpx 
activities were measured spectrophotometrically 
according to the methods of Ohishi et al.11, Wang et 
al.12 and Paglia et al.13. 
 
Statistical analysis 
Data were expressed as (mean±SD) for quantitative 
variables, numbers and percentage for qualitative 
variables. The comparison between groups was 
performed with one way analysis of variance 
(ANOVA): f test, t test, paired t test, chi-squared 
(χ2) or Fisher exact test when appropriate. 
Correlations were assessed by Pearson's test (r).  P-




SOD and Gpx were significantly lower in 
asthmatics than the control group.  Lower SOD 
level was noticed before than after treatment. MDA 
was significantly higher in asthmatics, and its level 
was higher during the acute attack before treatment 
(table 2). Before treatment, SOD showed lower 
levels in moderate and severe asthma than mild 
asthma. Gpx showed no difference between mild, 
moderate and severe asthmatics. MDA was 
significantly higher in severe asthma, than moderate 
asthma. Mild ones showed the lowest levels (table 
3). After treatment SOD and Gpx showed no 
difference among mild, moderate and severe 
asthmatics. MDA showed higher levels in severe 
asthmatics than mild and moderate ones (table 4). 
There was a significant positive correlation between 
SOD and Gpx in asthmatics before treatment, 
(figure 1). Gpx and MDA correlated negatively 
both before and after treatment [r -0.057, -0.29, p 
<0.001, <0.05 respectively] (figure 2).
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Table 1. Demographic data of the studied cases. 
 
History (N = 40) N (%) 
Residence:    
Urban 
Rural 
Housing:       
good aeration                                 
Sun exposure of carpets 
House hold pets  




breast milk only 
Introduction of cow milk in the first year 
Good intake of fresh fruits & vegetables 
Food allergy 
Atopy other than asthma 
Precipitating factors:           
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Table 2. Anti-oxidant enzyme activities and malondialdehyde levels in asthmatics 
(before and after treatment) and in the control group. 







SOD 23.17 ± 2.1 25.9 ± 2.4 28.7 ± 3.1 6.4 <0.001 
Gpx 47.86 ± 3.1 48.2 ± 2.9 54.5 ± 4.9 1.07 >0.05 
MDA 19.8 ± 6.6 11.1 ± 5.2 7.6 ± 2.3 7.82 <0.001 
SOD: super oxide dismutase, Gpx: glutathione peroxidases, MDA: Malondialdehyde, p<0.05 significant 
 
 
Table 3. Pre-treatment antioxidant enzyme activities and 
malondialdehyde levels in different degrees of asthma severity. 
Parameter Severity 
F P 




24.2 ± 1.2 
48.4 ± 3.6  
13.1 ± 2.6  
22.9 ± 2.4 
48.6 ± 2.8  
20.1 ± 2.8 
22.1 ± 2.1 
45.8 ±2.2  











Table 4. Post-treatment antioxidant enzyme activities and 
malondialdehyde levels in different degrees of asthma severity. 
Parameter Severity 
F P 




27 ± 2.9 
48.8 ± 3.4  
9.1 ± 3.8 
25.1 ± 1.9 
48.8 ± 2.7  
10.3 ± 4.6 
25.5 ± 1.8 
46.2 ± 1.9  







SOD: super oxide dismutase, Gpx: glutathione peroxidases, MDA: Malondialdehyde, 
p<0.05 significant 
 
Shokry and El-Tarahony 
  38
 
































Figure 2. Correlation between SOD and MDA in cases before treatment. 
 
 
    





























Figure 3. Correlation between Gpx and MDA in cases (a) before and (b) after treatment.  
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DISCUSSION 
Asthma itself may cause physiological changes in 
serum antioxidant status, perhaps because of 
increased oxidant burden associated with the 
disease. Numerous disturbances of antioxidant 
defense mechanisms have been described in 
asthma14. The situation gets further aggravated 
during acute exacerbations of asthma15. 
Our study demonstrated a significant decrease 
in erythrocyte SOD and Gpx enzymes activities in 
asthmatic children; either during acute attack or 
after 48 hours of treatment. 
This finding was consistent with other 
observations4-6-16-17-18. In those studies, one sample 
was taken from the patient to test the antioxidant 
enzyme activity. In our study, we evaluated the 
antioxidant enzymes twice to detect the effect of 
treatment. We found significant lower activity of 
erythrocyte SOD enzyme but not Gpx enzyme 
before than after treatment. 
   A parallel study documented loss of reducing 
potential by non-enzymatic and enzymatic 
antioxidants in asthma as compared to healthy 
individuals, with lowest levels in those patients 
with the most severe asthma14. 
In our study we found that SOD enzyme 
activity during the acute attack of asthma was 
affected by disease severity; where it was 
significantly higher in mild than moderate and 
severe asthmatics. This result was consistent with 
other studies6-19-20. After 48 hours of treatment, the 
SOD activity became comparable in different 
grades of asthma. 
Gpx enzyme activity was not affected by the 
severity of asthma both before and after 48 hours of 
treatment. A similar result was observed by Mak et 
al.21. On the other hand, Al-Faleg et al.22 found that 
there was no significant correlation between 
severity of asthma and the various measured SOD 
and Gpx activities.    
In consistence with many other observations17-
22-23-24 our study revealed a significant elevation of 
MDA plasma level among the asthmatic children 
both during the acute attack and after 48 hours of 
treatment compared to control group with the level 
being significantly higher before than after 
treatment. 
We also found that plasma level of MDA 
during the acute attack was related to severity. 
MDA level was significantly higher in severe than 
moderate and mild cases, both before and after 
treatment. 
So in general, asthma severity could be related 
to the extent of lipid peroxidation, with a positive 
association between MDA concentration and 
disease severity. This was similar to the findings of 
other studies25-26.   
The documented decrease in plasma level of 
MDA after 48 hours of treatment in our results is 
also supported by the findings of Sharma et al.3. 
They reported that serum MDA levels were highest 
at the time of admission, and decreased 
significantly at 24–48 hours with treatment. After a 
3 weeks symptom free interval serum MDA levels 
had decreased further but remained higher than 
those of healthy control group. So, they concluded 
that lipid peroxidation is increased in bronchial 
asthma during an acute attack and symptom free 
period as well3. 
The increase in reactive oxygen species (ROS) 
during asthmatic attack, as demonstrated indirectly 
by significant elevation of MDA, might overwhelm 
endogenous antioxidant defenses. This finding was 
illustrated in the present work by the low levels of 
two antioxidant enzymes SOD and Gpx and it is in 
agreement with the observations of other 
researchers25-26. 
In our cases, we found a significant negative 
correlation between plasma level of MDA and both 
of erythrocyte SOD and Gpx enzymes activities 
during the acute attack. This was in agreement with 
the observations of other researchers14. After 
treatment, the negative correlation was detected 
only between MDA and Gpx. 
In conclusion, asthmatic patients suffer from 
an oxidative stress as indicated by the high level of 
the oxidant MDA and low level of the antioxidant 
enzymes SOD and Gpx. This oxidant-antioxidant 
imbalance is related to the severity of asthma, 
especially during the acute attack and is more 
evident before treatment. The possibility of the 
introduction of antioxidants as a line of treatment of 
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